Dando Samantha J, Ipe Deepak S, Batzloff Michael, Sullivan Matthew J, Crossman David K, Crowley Michael, Strong Emily, Kyan Stephanie, Leclercq Sophie Y, Ekberg Jenny A K, St John James, Beacham Ifor R, Ulett Glen C
Institute for Glycomics, Griffith University, Gold Coast, Australia.
School of Medical Science, and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
Infect Immun. 2016 Jun 23;84(7):1941-1956. doi: 10.1128/IAI.01546-15. Print 2016 Jul.
Melioidosis, caused by the bacterium Burkholderia pseudomallei, is an often severe infection that regularly involves respiratory disease following inhalation exposure. Intranasal (i.n.) inoculation of mice represents an experimental approach used to study the contributions of bacterial capsular polysaccharide I (CPS I) to virulence during acute disease. We used aerosol delivery of B. pseudomallei to establish respiratory infection in mice and studied CPS I in the context of innate immune responses. CPS I improved B. pseudomallei survival in vivo and triggered multiple cytokine responses, neutrophil infiltration, and acute inflammatory histopathology in the spleen, liver, nasal-associated lymphoid tissue, and olfactory mucosa (OM). To further explore the role of the OM response to B. pseudomallei infection, we infected human olfactory ensheathing cells (OECs) in vitro and measured bacterial invasion and the cytokine responses induced following infection. Human OECs killed >90% of the B. pseudomallei in a CPS I-independent manner and exhibited an antibacterial cytokine response comprising granulocyte colony-stimulating factor, tumor necrosis factor alpha, and several regulatory cytokines. In-depth genome-wide transcriptomic profiling of the OEC response by RNA-Seq revealed a network of signaling pathways activated in OECs following infection involving a novel group of 378 genes that encode biological pathways controlling cellular movement, inflammation, immunological disease, and molecular transport. This represents the first antimicrobial program to be described in human OECs and establishes the extensive transcriptional defense network accessible in these cells. Collectively, these findings show a role for CPS I in B. pseudomallei survival in vivo following inhalation infection and the antibacterial signaling network that exists in human OM and OECs.
类鼻疽是由类鼻疽伯克霍尔德菌引起的一种常较为严重的感染,吸入暴露后常累及呼吸系统疾病。经鼻内(i.n.)接种小鼠是一种用于研究细菌荚膜多糖I(CPS I)在急性疾病期间对毒力贡献的实验方法。我们使用类鼻疽伯克霍尔德菌的气溶胶递送在小鼠中建立呼吸道感染,并在固有免疫反应的背景下研究CPS I。CPS I提高了类鼻疽伯克霍尔德菌在体内的存活率,并引发了多种细胞因子反应、中性粒细胞浸润以及脾脏、肝脏、鼻相关淋巴组织和嗅黏膜(OM)中的急性炎症组织病理学变化。为了进一步探索OM对类鼻疽伯克霍尔德菌感染反应的作用,我们在体外感染了人嗅鞘细胞(OECs),并测量了细菌入侵以及感染后诱导的细胞因子反应。人OECs以不依赖CPS I的方式杀死了>90%的类鼻疽伯克霍尔德菌,并表现出一种抗菌细胞因子反应,包括粒细胞集落刺激因子、肿瘤坏死因子α和几种调节性细胞因子。通过RNA-Seq对OEC反应进行深入的全基因组转录组分析,揭示了感染后OECs中激活的信号通路网络,涉及一组新的378个基因,这些基因编码控制细胞运动、炎症、免疫疾病和分子运输的生物学途径。这代表了在人OECs中描述的第一个抗菌程序,并建立了这些细胞中可利用的广泛转录防御网络。总的来说,这些发现表明CPS I在吸入感染后类鼻疽伯克霍尔德菌在体内的存活中发挥作用,以及人OM和OECs中存在的抗菌信号网络。